CLINICAL_TRIALS
trial_result
· 2011-11-02
Clinical Trial Update: Long Term Efficacy and Safety of FTY720 in de Novo Adult Renal Transplant Recipients [Phase 3]
Summary
Phase 3 trial evaluating long-term efficacy and safety of fingolimod (FTY720) in de novo adult renal transplant recipients has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis Pharmaceuticals | Conditions: Renal Transplantation | Phase 3 | Status: COMPLETED